EW Stock Overview
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for EW from our risk checks.
Edwards Lifesciences Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$68.36 |
| 52 Week High | US$94.87 |
| 52 Week Low | US$60.57 |
| Beta | 1.02 |
| 1 Month Change | 1.92% |
| 3 Month Change | -10.50% |
| 1 Year Change | -10.70% |
| 3 Year Change | -20.29% |
| 5 Year Change | 30.45% |
| Change since IPO | 4,871.64% |
Recent News & Updates
Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets
Oct 26Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23
Recent updates
Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets
Oct 26Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Oct 09Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Sep 26A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Sep 11Edwards Lifesciences: Rising Dominance In Structural Heart Disease
Aug 21Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jul 16Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?
Jun 30Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Jun 15Edwards Lifesciences: Valuation Premium Earned, But Shares Are Not Cheap, Technicals Mixed
Jun 12Are Edwards Lifesciences Corporation (NYSE:EW) Investors Paying Above The Intrinsic Value?
May 31Edwards Lifesciences (NYSE:EW) Has A Rock Solid Balance Sheet
Apr 03What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?
Mar 22Investors Shouldn't Overlook The Favourable Returns On Capital At Edwards Lifesciences (NYSE:EW)
Mar 10Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Feb 26Edwards Lifesciences downgraded to market perform at Raymond James on growth challenges
Feb 06Edwards Lifesciences slips as Piper downgrades on challenging setup
Jan 30Edwards Lifesciences: Short-Term Growth Worries Have Created An Opportunity
Jan 18Edwards Lifesciences: Catalysts For 2023 And Beyond
Dec 30Is Edwards Lifesciences (NYSE:EW) A Risky Investment?
Dec 28Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?
Dec 16Edwards Lifesciences CEO Michael Mussallem to retire
Dec 08Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital
Dec 04Estimating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Nov 22Edwards Lifesciences down 11% after Q3 misses, revised 2022 EPS guidance
Oct 27Edwards Lifesciences (NYSE:EW) Seems To Use Debt Rather Sparingly
Sep 22Edwards Lifesciences wins FDA approval for PASCAL transcatheter valve repair system
Sep 15Why Edwards Lifesciences Corporation (NYSE:EW) Could Be Worth Watching
Sep 10Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital
Aug 29Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Aug 17Edwards Lifesciences: Stretched Valuation And Bearish Resistance In Play
Aug 15Edwards Lifesciences stock down ~6% after hours on Q2 results miss, slashed FY guidance
Jul 28Edwards Lifesciences (NYSE:EW) Could Easily Take On More Debt
Jun 13Edwards Lifesciences: Seeking 60% Upside For Potential Exit At $160 Per Share
Jun 02Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Jun 02Shareholder Returns
| EW | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0.7% | 1.0% | 1.1% |
| 1Y | -10.7% | -2.3% | 11.7% |
Return vs Industry: EW underperformed the US Medical Equipment industry which returned -2.3% over the past year.
Return vs Market: EW underperformed the US Market which returned 11.7% over the past year.
Price Volatility
| EW volatility | |
|---|---|
| EW Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: EW is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: EW's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 17,300 | Bernard Zovighian | https://www.edwards.com |
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy.
Edwards Lifesciences Corporation Fundamentals Summary
| EW fundamental statistics | |
|---|---|
| Market Cap | US$41.46b |
| Earnings (TTM) | US$1.43b |
| Revenue (TTM) | US$5.82b |
29.0x
P/E Ratio7.1x
P/S RatioIs EW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EW income statement (TTM) | |
|---|---|
| Revenue | US$5.82b |
| Cost of Revenue | US$1.28b |
| Gross Profit | US$4.54b |
| Other Expenses | US$3.11b |
| Earnings | US$1.43b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.36 |
| Gross Margin | 77.99% |
| Net Profit Margin | 24.59% |
| Debt/Equity Ratio | 8.9% |
How did EW perform over the long term?
See historical performance and comparison